Dynacirc and Nail discomfort - a phase IV clinical study of FDA data
Summary:
We study 1,107 people who take Dynacirc (isradipine) or have Nail discomfort. No report of Nail discomfort is found in people who take Dynacirc.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Dynacirc?
Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.
What is Nail Discomfort?
Nail discomfort is found to be associated with 30 drugs and 122 conditions by eHealthMe. Check the latest studies of Nail discomfort.
No report is found.
Do you take Dynacirc and have Nail discomfort?
- Check whether Nail discomfort is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Dynacirc:
- Dynacirc (975 reports)
Nail discomfort treatments and more:
- Nail discomfort (132 reports)
How severe was Nail discomfort and when was it recovered:
Expand to all the drugs that have ingredients of isradipine:
Browse all side effects of Dynacirc:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nail discomfort:
Browse all the conditions that are associated with Nail discomfort:
How the study uses the data?
The study uses data from the FDA. It is based on isradipine (the active ingredients of Dynacirc) and Dynacirc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Diphenhydramine Hydrochloride cause Thrombocytopenia? - a second ago
- Mefenamic Acid and Bone And Joint Pain for Women aged 30-39 - 3 seconds ago
- Mefenamic Acid and Joint Aches for Women aged 30-39 - 3 seconds ago
- Mefenamic Acid and Stiffness In A Joint for Women aged 30-39 - 3 seconds ago
- Mefenamic Acid and Pain - Joints for Women aged 30-39 - 4 seconds ago
- Mefenamic Acid and Arthralgia for Women aged 30-39 - 4 seconds ago
- Mefenamic Acid and Joint Pain for Women aged 30-39 - 4 seconds ago
- Nausea And Vomiting and drugs of ingredients of trametinib dimethyl sulfoxide - 5 seconds ago
- Crohn'S Disease and Abdominal Pain Upper - 5 seconds ago
- Could Lasix cause Renal Failure Aggravated? - 14 seconds ago